Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women

AIDS

Volumn 25, Issue 5, 2011, Pages 619-623

  Delwart, Eric ^a,b   Bernardin, Flavien ^a   Lee, Tzong Hae ^a   Winkelman, Valerie ^c   Liu, Chenglong ^d   Sheppard, Haynes ^e   Liu, Albert ^f   Greenblatt, Ruth ^f   Anastos, Katryn ^g   Dehovitz, Jack ^h   Nowicki, Marek ⁱ   Cohen, Mardge ^j   Golub, Elizabeth T ^k   Barbour, Jason ^b   Buchbinder, Susan ^f   Busch, Michael P ^a,b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CREATIVE TESTING SOLUTIONS   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

^h SUNY DOWNSTATE MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j RUSH MEDICAL COLLEGE   (United States)

^k JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

acute infections; preseroconversion; transcription mediated amplification; transient infections; window phase

Indexed keywords

GENOMIC DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVIRUS; REPRODUCIBILITY; SEROCONVERSION; VIREMIA;

FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; MALE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; VIREMIA; VIRUS REPLICATION;

EID: 79952440267     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283440269     Document Type: Article

References (34)

1. Kaul R, Plummer FA, Kimani J, Dong T, Kiama P, Rostron T, et al. HIV-1-specific mucosal CD8R lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000; 164:1602-1611. (Pubitemid 30067280)
2. Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T, Kiama P, et al. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 2001; 79:3-13. (Pubitemid 32938202)
3. Goh WC, Markee J, Akridge RE, Meldorf M, Musey L, Karchmer T, et al. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J Infect Dis 1999; 179:548-557. (Pubitemid 30016137)
4. Akridge R, Hladik F, Markee J, Alef C, Kelley H, Collier A, et al. Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure. Immunol Lett 1999; 66: 15-19. (Pubitemid 29136813)
5. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998; 102:1758-1765. (Pubitemid 28516261)
6. Rowland-Jones SL, Dong T, Dorrell L, Ogg G, Hansasuta P, Krausa P, et al. Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunol Lett 1999; 66:9-14. (Pubitemid 29136812)
7. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993; 341:860-861. (Pubitemid 23094512)
8. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995; 1:59-64.
9. Wolinsky SM, Rinaldo CR, Kwok S, Sninsky JJ, Gupta P, Imagawa D, et al. Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men. Ann Intern Med 1989; 111:961-972. (Pubitemid 20034920)
10. Imagawa DT, Lee MH, Wolinsky SM, Sano K, Morales F, Kwok S, et al. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med 1989; 320:1458-1462. (Pubitemid 19143711)
11. Zhu T, Corey L, Hwangbo Y, Lee JM, Learn GH, Mullins JI, et al. Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J Virol 2003; 77:6108-6116. (Pubitemid 36588382)
12. Ma ZM, Abel K, Rourke T, Wang Y, Miller CJ. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J Virol 2004; 78:14048-14052. (Pubitemid 39612802)
13. Miller CJ, Marthas M, Torten J, Alexander NJ, Moore JP, Doncel GF, et al. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol 1994; 68:6391-6400. (Pubitemid 24294889)
14. McChesney MB, Collins JR, Lu D, Lu X, Torten J, Ashley RL, et al. Occult systemic infection and persistent simian immunodefi-ciency virus (SIV)-specific CD4(R)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 1998; 72:10029-10035. (Pubitemid 28520871)
15. Pauza CD, Emau P, Salvato MS, Trivedi P, MacKenzie D, Malkovsky M, et al. Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J Med Primatol 1993; 22:154-161.
16. Trivedi P, Horejsh D, Hinds SB, Hinds PW II, Wu MS, Salvato MS, et al. Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia. J Virol 1996; 70:6876-6883. (Pubitemid 26307400)
17. Zhu T, Hu SL, Feng F, Polacino P, Liu H, Hwangbo Y, et al. Persistence of low levels of simian immunodeficiency virus in macaques that were transiently viremic by conventional testing. Virology 2004; 323:208-219. (Pubitemid 38748469)
18. Frenkel LM, Mullins JI, Learn GH, Manns-Arcuino L, Herring BL, Kalish ML, et al. Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science 1998; 280:1073-1107.
19. McClure MO, Bieniasz PD, Weber JN, Tedder RS, O'Shea S, Banatvala JE, et al. HIV clearance in an infant? Nature 1995; 375:637-638.
20. Liu Y, Woodward A, Zhu H, Andrus T, McNevin J, Lee J, et al. Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners. J Virol 2009; 83:10821-10829.
21. SheppardHW, LangW, AscherMS, Vittinghoff E, Winkelstein W. The characterization of nonprogressors: long term HIV-1 infection with stable CD4R T-cell levels. AIDS 1993; 7:1159-1166. (Pubitemid 23270961)
22. Byers RH, Morgan WM, Darrow WW, Doll L, Jaffe HW, Rutherford G, et al. Estimating AIDS infection rates in the San Francisco cohort. AIDS 1988; 2:207-210.
23. Jaffe HW, Darrow WW, Echenberg DF, O'Malley PM, Getchell JP, Kalyanaraman VS, et al. The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study. Ann Intern Med 1985; 103:210-214. (Pubitemid 15000571)
24. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9:117-125. (Pubitemid 28157608)
25. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351:760-768.
26. Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, McAuley J, et al. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion 2005; 45:1853-1863. (Pubitemid 43971412)
27. Lelie PN, van Drimmelen HA, Cuypers HT, Best SJ, Stramer SL, Hyland C, et al. Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion 2002; 42:527-536.
28. Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, et al. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol 2009; 83:329-335.
29. Hatano H, Delwart EL, Norris PJ, Lee TH, Neilands TB, Kelley CF, et al. Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals. AIDS 2010; 24:2535-2539.
30. Lee TH, Chafets DM, Reed W, Wen L, Yang Y, Chen J, et al. Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms. Transfusion 2006; 46:1870-1878. (Pubitemid 44631592)
31. Liu J, Keele BF, Li H, Keating S, Norris PJ, Carville A, et al. Lowdose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J Virol 2010; 84:10406-10412.
32. Keele BF, Li H, Learn GH, Hraber P, Giorgi EE, Grayson T, et al. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med 2009; 206:1117-1134.
33. Miller CJ, Li Q, Abel K, Kim EY, Ma ZM, Wietgrefe S, et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 2005; 79:9217-9227. (Pubitemid 40934833)
34. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464:217-223.